Intravitreal Ranibizumab Versus Aflibercept for Diabetic Macular Edema in Vitrectomized Eyes: 12 Month Results
Author:
Affiliation:
1. Department of Ophthalmology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey
Funder
no funding
Publisher
Informa UK Limited
Subject
Ophthalmology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/08820538.2021.1900287
Reference18 articles.
1. Macular edema
2. Photocoagulation for Diabetic Macular Edema
3. Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials
4. An efficacy comparison of anti-vascular growth factor agents and laser photocoagulation in diabetic macular edema: a network meta-analysis incorporating individual patient-level data
5. Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy;Cochrane Database of Systematic Reviews;2023-05-31
2. Efficacy and safety of corticosteroids versus standard therapy in alleviating diabetic retinopathy among Chinese patients with uncontrolled diabetes;Pakistan Journal of Pharmaceutical Sciences;2023-01-05
3. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy;Cochrane Database of Systematic Reviews;2010-01-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3